New immune cell therapy targets Tough-to-Treat leukemias
Disease control
Recruiting now
This early-stage study is testing an experimental treatment called CART84 for adults with acute myeloid leukemia (AML) or T-cell acute lymphoblastic leukemia (T-ALL) that has come back or not responded to other treatments. CART84 is a type of CAR-T therapy, where a patient's own …
Phase: PHASE1, PHASE2 • Sponsor: Gyala Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC